The page lists 26 projects related to the topic "ipscs".
# | |||
---|---|---|---|
1 | REPROWORM | Safeguarding Cell Identities: Mechanisms Counteracting Cell Fate Reprogramming | 2015 |
2 | TrainMALTA | Interdisciplinary Training in High-Throughput Sequencing, Bioinformatics and Model Systems: Moving towards Clinical applications of Genomics | 2016 |
3 | SysMedPD | Systems Medicine of Mitochondrial Parkinson’s Disease | 2015 |
4 | ReachingCompleteness | The Molecular Basis of Somatic Nuclear Reprogramming | 2016 |
5 | CAiPSC | Determining centromere assembly mechanisms and improving mitotic fidelity during somatic cell reprogramming | 2016 |
6 | iPSCAtaxia | An induced pluripotent stem cell-based neuronal model of Spinocerebellar ataxia | 2016 |
7 | NGN-PET | Modelling Neuron-Glia Networks into a drug discovery platform for Pain Efficacious Treatments - Sofia ref.: 116072 | 2017 |
8 | CellKarma | Dissecting the regulatory logic of cell fate reprogramming through integrative and single cell genomics | 2018 |
9 | CELLNAIVETY | Deciphering the Molecular Foundations and Functional Competence of Alternative Human Naïve Pluripotent Stem Cells | 2017 |
10 | CISTEM | Heart On chip based on induced pluripotent Stem cell Technology for personalized Medicine | 2018 |
11 | ORI NUMBER | Unravelling the effect of origin number on the success of genome replication | 2017 |
12 | ELECTRO NEEDLE | In situ stem cell monitoring system based on conductive nanoneedle devices for tracking cell fates in invasive manner | 2018 |
13 | LEUKEYOLK | Uncovering the origin and mechanisms of Down syndrome-associated leukaemia through human induced pluripotent stem cell-derived haemopoiesis | 2019 |
14 | MiniBRAIN | Investigating the pathogenic mechanisms underlying TUBB2B-related brain malformations using induced pluripotent stem cells and cerebral organoids. | 2019 |
15 | V.A. Cure | A multidisciplinary approach towards sustainable improvement in rare diseases care uniting Europe's top class vascular research to find new treatment strategies for vascular anomalies | 2019 |
16 | DiRECT | Directly reprogrammed renal cells for targeted medicine | 2019 |
17 | iP-OSTEO | Induced pluripotent stem cell seeded active osteochondral nanofibrous scaffolds | 2019 |
18 | Neurovulnerability | Molecular mechanisms underlying selective neuronal death in motor neuron diseases | 2019 |
19 | SYNKIT | Synthetic Natural Killer Cells for Immunotherapy | 2020 |
20 | NeuroStemX | In vitro model of Fragile X Syndrome using naïve iPSCs | 2019 |
21 | iMIND | iPS-derived MIcroglia and Neuroinflammation in Dementia | 2020 |
22 | DADA2GT | Development of gene therapy and genome editing strategies to treat adenosine deaminase 2 deficiency | 2019 |
23 | COMMER-CELL | Commercialisation of neuronal cell co-cultures | 2019 |
24 | EBiSC2 | EBiSC2 – A sustainable European Bank for induced pluripotent Stem Cells | 2019 |
25 | ActiTOX | Active organotypic models for nanoparticle toxicological screening | 2019 |
26 | BrainCircuit-on-chip | Microfluidic chambers for establishing physiological and pathological human iPSC-derived neuronal circuits | 2019 |